Savara (SVRA) Financials

$2.87 -0.06 (-1.91%)

As of 01:58 PM Eastern

Annual Income Statements for Savara

This table shows Savara's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-96	-55	-38
Consolidated Net Income / (Loss)	-96	-55	-38
Net Income / (Loss) Continuing Operations	-96	-55	-38
Total Pre-Tax Income	-97	-55	-39
Total Operating Income	-103	-60	-39
Total Gross Profit	0.00	0.00	0.00
Total Revenue	0.00	0.00	0.00
Operating Revenue	0.00	0.00	0.00
Total Cost of Revenue	0.00	0.00	0.00
Total Operating Expenses	103	60	39
Selling, General & Admin Expense	25	16	11
Research & Development Expense	78	44	28
Depreciation Expense	0.13	0.08	0.03
Total Other Income / (Expense), net	6.52	4.51	-0.11
Interest & Investment Income	6.47	4.44	-0.09
Other Income / (Expense), net	0.05	0.08	-0.02
Income Tax Expense	-0.80	-0.80	-0.80
Basic Earnings per Share	($0.48)	($0.33)	($0.25)
Weighted Average Basic Shares Outstanding	198.19M	165.20M	152.77M
Diluted Earnings per Share	($0.48)	($0.33)	($0.25)
Weighted Average Diluted Shares Outstanding	198.19M	165.20M	152.77M
Weighted Average Basic & Diluted Shares Outstanding	172.63M	138.15M	114.06M

This table shows Savara's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-29	-24	-22	-20	-16	-17	-11	-11	-10	-10
Consolidated Net Income / (Loss)	-29	-24	-22	-20	-16	-17	-11	-11	-10	-10
Net Income / (Loss) Continuing Operations	-29	-24	-22	-20	-16	-17	-11	-11	-10	-10
Total Pre-Tax Income	-53	0.00	-22	-21	-33	0.00	-11	-11	-10	-10
Total Operating Income	-31	-26	-23	-22	-18	-18	-12	-12	-11	-11
Total Operating Expenses	31	26	23	22	18	18	12	12	11	11
Selling, General & Admin Expense	7.85	6.01	5.54	5.64	4.85	4.15	3.30	3.37	3.24	2.38
Research & Development Expense	23	20	18	17	13	14	8.91	8.74	7.63	8.15
Depreciation Expense	0.03	0.03	0.03	0.03	0.03	0.03	0.01	0.01	0.01	0.01
Total Other Income / (Expense), net	2.13	2.11	0.95	1.33	1.53	1.45	0.74	0.79	0.57	0.14
Interest & Investment Income	1.91	2.13	1.07	1.35	1.52	1.44	0.71	0.77	0.61	0.15
Other Income / (Expense), net	0.22	-0.02	-0.13	-0.02	0.01	0.00	0.03	0.03	-0.04	-0.01
Basic Earnings per Share	($0.14)	($0.11)	($0.12)	($0.11)	($0.09)	($0.10)	($0.07)	($0.07)	($0.07)	($0.07)
Weighted Average Basic Shares Outstanding	198.19M	211.85M	182.58M	182.55M	165.20M	174.70M	152.80M	152.78M	152.77M	152.77M
Diluted Earnings per Share	($0.14)	($0.11)	($0.12)	($0.11)	($0.09)	($0.10)	($0.07)	($0.07)	($0.07)	($0.07)
Weighted Average Diluted Shares Outstanding	198.19M	211.85M	182.58M	182.55M	165.20M	174.70M	152.80M	152.78M	152.77M	152.77M
Weighted Average Basic & Diluted Shares Outstanding	172.63M	171.62M	164.60M	138.19M	138.15M	135.34M	135.17M	114.07M	114.06M	114.04M

This table details how cash moves in and out of Savara's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	-11	-26	18
Net Cash From Operating Activities	-89	-51	-35
Net Cash From Continuing Operating Activities	-89	-51	-35
Net Income / (Loss) Continuing Operations	-96	-55	-38
Consolidated Net Income / (Loss)	-96	-55	-38
Depreciation Expense	0.13	0.08	0.03
Amortization Expense	-5.17	-4.71	0.55
Non-Cash Adjustments To Reconcile Net Income	10	4.20	2.06
Changes in Operating Assets and Liabilities, net	1.83	4.07	0.96
Net Cash From Investing Activities	-40	-57	53
Net Cash From Continuing Investing Activities	-40	-57	53
Purchase of Property, Plant & Equipment	-0.03	-0.30	-0.01
Purchase of Investments	-205	-194	-89
Sale and/or Maturity of Investments	165	137	142
Net Cash From Financing Activities	118	83	0.09
Net Cash From Continuing Financing Activities	118	83	0.09
Repayment of Debt	0.00	0.00	-26
Repurchase of Common Equity	-1.00	-1.21	-0.00
Issuance of Debt	0.00	0.00	26
Issuance of Common Equity	118	84	0.00
Other Financing Activities, net	0.40	0.28	0.00
Effect of Exchange Rate Changes	-0.01	-0.12	-0.09
Cash Interest Paid	2.12	2.04	1.61

This table details how cash moves in and out of Savara's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-6.30	-2.44	7.08	-9.80	-1.11	4.95	-11	-18	-68	25
Net Cash From Operating Activities	-23	-23	-22	-21	-16	-13	-10	-12	-8.65	-8.16
Net Cash From Continuing Operating Activities	-23	-23	-22	-21	-16	-13	-10	-12	-8.65	-8.16
Net Income / (Loss) Continuing Operations	-29	-24	-22	-20	-16	-17	-11	-11	-10	-10
Consolidated Net Income / (Loss)	-29	-24	-22	-20	-16	-17	-11	-11	-10	-10
Depreciation Expense	0.03	0.03	0.03	0.03	0.03	0.03	0.01	0.01	0.01	0.01
Amortization Expense	-1.51	-1.37	-1.02	-1.27	-1.64	-1.41	-0.83	-0.84	-0.25	0.16
Non-Cash Adjustments To Reconcile Net Income	3.02	2.39	2.32	2.28	1.45	0.99	0.93	0.84	0.60	0.46
Changes in Operating Assets and Liabilities, net	4.06	0.70	-1.58	-1.34	0.65	3.82	1.07	-1.47	1.30	1.59
Net Cash From Investing Activities	18	-98	30	11	6.57	-57	-1.01	-6.10	-59	33
Net Cash From Continuing Investing Activities	18	-98	30	11	6.57	-57	-1.01	-6.10	-59	33
Purchase of Property, Plant & Equipment	0.01	-0.00	-0.02	-0.01	-0.02	-0.04	-0.23	-0.00	-	-0.00
Purchase of Investments	-32	-139	-3.44	-31	-39	-95	-31	-30	-73	-
Sale and/or Maturity of Investments	50	41	33	42	45	38	30	24	14	33
Net Cash From Financing Activities	-0.84	118	0.06	0.05	7.90	75	0.10	0.03	0.00	-0.00
Net Cash From Continuing Financing Activities	-0.84	118	0.06	0.05	7.90	75	0.10	0.03	0.00	-0.00
Repurchase of Common Equity	-0.90	-0.09	-0.00	-0.00	-1.03	-0.18	-	-0.00	-0.00	-0.00
Issuance of Common Equity	-0.00	118	-	0.00	8.83	75	-	0.00	-	-
Other Financing Activities, net	0.06	0.24	0.06	0.05	0.09	0.06	0.10	0.03	0.00	-
Effect of Exchange Rate Changes	-0.07	0.08	-0.02	0.00	0.03	-	-	-0.02	0.12	-
Cash Interest Paid	0.51	0.54	0.54	0.54	0.54	0.53	0.51	0.46	0.43	0.33

This table presents Savara's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	213	178	140
Total Current Assets	202	166	129
Cash & Equivalents	15	27	52
Short-Term Investments	181	136	74
Prepaid Expenses	5.81	3.63	3.08
Plant, Property, & Equipment, net	0.17	0.27	0.05
Total Noncurrent Assets	11	11	11
Other Noncurrent Operating Assets	11	11	11
Total Liabilities & Shareholders' Equity	213	178	140
Total Liabilities	41	37	32
Total Current Liabilities	15	11	5.87
Short-Term Debt	0.00	0.00	0.00
Accounts Payable	4.55	3.50	1.33
Accrued Expenses	10	7.09	4.53
Total Noncurrent Liabilities	27	27	26
Long-Term Debt	27	26	26
Other Noncurrent Operating Liabilities	0.09	0.25	0.05
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	171	140	108
Total Preferred & Common Equity	171	140	108
Total Common Equity	171	140	108
Common Stock	661	534	447
Retained Earnings	-489	-393	-339
Accumulated Other Comprehensive Income / (Loss)	-0.75	-0.27	-0.61

This table presents Savara's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	239	140	158	182	120	129	148
Total Current Assets	226	128	146	170	108	118	137
Cash & Equivalents	21	24	17	28	23	34	120
Short-Term Investments	198	98	126	141	82	81	14
Prepaid Expenses	6.96	6.18	3.14	1.85	2.72	2.85	2.99
Plant, Property, & Equipment, net	0.21	0.24	0.25	0.28	0.26	0.05	0.06
Total Noncurrent Assets	12	12	12	12	12	12	11
Other Noncurrent Operating Assets	12	12	12	12	12	12	11
Total Liabilities & Shareholders' Equity	239	140	158	182	120	129	148
Total Liabilities	39	38	36	36	32	31	31
Total Current Liabilities	13	11	9.81	8.96	5.89	4.92	5.16
Short-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable	4.61	3.39	2.85	3.22	2.50	1.57	0.89
Accrued Expenses	8.18	7.90	6.96	5.74	3.38	3.35	4.27
Total Noncurrent Liabilities	27	27	27	27	26	26	26
Long-Term Debt	27	26	26	26	26	26	26
Other Noncurrent Operating Liabilities	0.13	0.17	0.21	0.28	0.02	0.04	0.07
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	199	102	122	147	88	98	117
Total Preferred & Common Equity	199	102	122	147	88	98	117
Total Common Equity	199	102	122	147	88	98	117
Common Stock	659	539	536	525	449	448	446
Retained Earnings	-460	-436	-414	-377	-361	-349	-328
Accumulated Other Comprehensive Income / (Loss)	0.30	-0.88	-0.74	-0.94	-0.62	-0.46	-1.61

This table displays calculated financial ratios and metrics derived from Savara's official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	0.00%	0.00%	0.00%
EBITDA Growth	-67.56%	-68.66%	1.97%
EBIT Growth	-72.11%	-54.23%	6.54%
NOPAT Growth	-71.97%	-54.50%	6.36%
Net Income Growth	-75.29%	-43.38%	11.31%
EPS Growth	-45.45%	-32.00%	21.88%
Operating Cash Flow Growth	-74.47%	-47.77%	13.79%
Free Cash Flow Firm Growth	-81.07%	-46.75%	14.76%
Invested Capital Growth	-60.44%	-44.85%	-11.17%
Revenue Q/Q Growth	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	-14.03%	-14.26%	-0.75%
EBIT Q/Q Growth	-14.85%	-12.59%	1.70%
NOPAT Q/Q Growth	-15.11%	-12.69%	-0.61%
Net Income Q/Q Growth	-15.61%	-11.86%	2.58%
EPS Q/Q Growth	-11.63%	-6.45%	-8.70%
Operating Cash Flow Q/Q Growth	-9.43%	-15.76%	2.02%
Free Cash Flow Firm Q/Q Growth	-7.63%	-15.04%	-2.57%
Invested Capital Q/Q Growth	-73.05%	-3.78%	-5.53%
Profitability Metrics	-	-	-
Gross Margin	0.00%	0.00%	0.00%
EBITDA Margin	0.00%	0.00%	0.00%
Operating Margin	0.00%	0.00%	0.00%
EBIT Margin	0.00%	0.00%	0.00%
Profit (Net Income) Margin	0.00%	0.00%	0.00%
Tax Burden Percent	99.18%	98.56%	97.96%
Interest Burden Percent	93.73%	92.60%	100.23%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%
Return on Equity (ROE)	-61.50%	-44.08%	-30.24%
Cash Return on Invested Capital (CROIC)	-2,265.62%	-620.72%	-308.72%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%
Return on Assets (ROA)	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	-61.50%	-44.08%	-30.24%
Return on Equity Simple (ROE_SIMPLE)	-55.92%	-38.97%	-35.40%
Net Operating Profit after Tax (NOPAT)	-72	-42	-27
NOPAT Margin	0.00%	0.00%	0.00%
Net Nonoperating Expense Percent (NNEP)	-15.47%	-10.77%	-9.32%
Return On Investment Capital (ROIC_SIMPLE)	-36.47%	-25.19%	-
Cost of Revenue to Revenue	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	0.00%	0.00%	0.00%
Earnings before Interest and Taxes (EBIT)	-103	-60	-39
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-108	-65	-38
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	3.07	4.53	1.64
Price to Tangible Book Value (P/TBV)	3.07	4.53	1.64
Price to Revenue (P/Rev)	0.00	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	205.15	113.64	9.65
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.16	0.19	0.24
Long-Term Debt to Equity	0.16	0.19	0.24
Financial Leverage	-0.98	-0.95	-0.93
Leverage Ratio	1.25	1.28	1.25
Compound Leverage Factor	1.17	1.18	1.26
Debt to Total Capital	13.44%	15.80%	19.48%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	13.44%	15.80%	19.48%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	86.56%	84.20%	80.52%
Debt to EBITDA	-0.25	-0.41	-0.68
Net Debt to EBITDA	1.57	2.11	2.61
Long-Term Debt to EBITDA	-0.25	-0.41	-0.68
Debt to NOPAT	-0.37	-0.63	-0.96
Net Debt to NOPAT	2.35	3.24	3.67
Long-Term Debt to NOPAT	-0.37	-0.63	-0.96
Altman Z-Score	3.87	7.10	0.06
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	13.73	15.66	21.98
Quick Ratio	13.33	15.32	21.45
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-70	-38	-26
Operating Cash Flow to CapEx	-356,352.00%	-17,250.34%	-383,933.33%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.00	0.00	0.00
Accounts Receivable Turnover	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-
Invested Capital	1.74	4.40	7.98
Invested Capital Turnover	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	-2.66	-3.58	-1.00
Enterprise Value (EV)	357	500	77
Market Capitalization	527	636	177
Book Value per Share	$1.00	$1.04	$0.95
Tangible Book Value per Share	$1.00	$1.04	$0.95
Total Capital	198	167	134
Total Debt	27	26	26
Total Long-Term Debt	27	26	26
Net Debt	-170	-136	-100
Capital Expenditures (CapEx)	0.03	0.30	0.01
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-8.92	-6.97	-2.79
Debt-free Net Working Capital (DFNWC)	187	155	123
Net Working Capital (NWC)	187	155	123
Net Nonoperating Expense (NNE)	24	13	11
Net Nonoperating Obligations (NNO)	-170	-136	-100
Total Depreciation and Amortization (D&A)	-5.04	-4.64	0.58
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%
Net Working Capital to Revenue	0.00%	0.00%	0.00%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.48)	($0.33)	($0.25)
Adjusted Weighted Average Basic Shares Outstanding	198.19M	165.20M	152.77M
Adjusted Diluted Earnings per Share	($0.48)	($0.33)	($0.25)
Adjusted Weighted Average Diluted Shares Outstanding	198.19M	165.20M	152.77M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	172.63M	138.15M	114.06M
Normalized Net Operating Profit after Tax (NOPAT)	-72	-42	-27
Normalized NOPAT Margin	0.00%	0.00%	0.00%
Pre Tax Income Margin	0.00%	0.00%	0.00%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	-1.04%	-2.21%	-0.01%

This table displays calculated financial ratios and metrics derived from Savara's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Growth	-68.75%	-42.72%	-86.81%	-83.73%	-72.19%	-87.26%	-42.17%	-69.99%	-2.61%	-11.24%
EBIT Growth	-75.72%	-46.19%	-91.29%	-86.18%	-61.40%	-71.14%	-30.48%	-49.93%	5.82%	-5.64%
NOPAT Growth	-76.82%	-46.07%	-89.76%	-85.56%	-62.11%	-71.28%	-30.25%	-50.53%	-2.22%	-5.65%
Net Income Growth	-80.41%	-46.08%	-94.38%	-92.73%	-56.30%	-59.82%	-24.87%	-27.19%	8.93%	1.52%
EPS Growth	-55.56%	-10.00%	-71.43%	-57.14%	-28.57%	-42.86%	-16.67%	-40.00%	-40.00%	0.00%
Operating Cash Flow Growth	-49.21%	-72.25%	-118.99%	-71.66%	-80.36%	-61.24%	-10.26%	-42.74%	7.60%	8.57%
Free Cash Flow Firm Growth	-118.69%	-132.21%	-109.85%	-48.97%	-32.57%	-48.90%	3.74%	10.07%	27.62%	39.06%
Invested Capital Growth	-60.44%	41.25%	-23.43%	-45.61%	-44.85%	-45.85%	-17.03%	-8.24%	-11.17%	-15.02%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	-17.02%	-14.04%	-2.41%	-24.10%	1.04%	-49.28%	-0.73%	-15.71%	-7.63%	-13.33%
EBIT Q/Q Growth	-17.36%	-13.13%	-3.64%	-27.69%	2.36%	-48.04%	-0.87%	-10.70%	-3.53%	-12.87%
NOPAT Q/Q Growth	-18.28%	-13.66%	-3.18%	-27.48%	2.29%	-47.65%	-0.90%	-11.37%	-3.23%	-12.28%
Net Income Q/Q Growth	-19.78%	-9.01%	-9.32%	-26.38%	3.01%	-45.06%	-8.39%	-2.50%	0.83%	-13.33%
EPS Q/Q Growth	-27.27%	8.33%	-9.09%	-22.22%	10.00%	-42.86%	0.00%	0.00%	0.00%	-16.67%
Operating Cash Flow Q/Q Growth	-2.70%	-0.77%	-8.97%	-32.31%	-18.56%	-28.12%	14.59%	-39.01%	-5.99%	12.39%
Free Cash Flow Firm Q/Q Growth	5.78%	-43.39%	-25.03%	-29.46%	-0.05%	-29.58%	11.24%	-15.20%	-12.38%	16.23%
Invested Capital Q/Q Growth	-73.05%	-3.55%	27.99%	18.93%	-3.78%	-47.72%	-9.08%	20.59%	-5.53%	-19.90%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profit (Net Income) Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Tax Burden Percent	54.50%	0.00%	100.00%	96.23%	49.24%	0.00%	99.69%	93.28%	99.99%	99.95%
Interest Burden Percent	172.15%	0.00%	95.40%	93.99%	185.60%	0.00%	94.18%	93.67%	94.37%	98.56%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-61.50%	-47.95%	-79.48%	-58.59%	-44.08%	-37.18%	-39.75%	-34.43%	-30.24%	-28.82%
Cash Return on Invested Capital (CROIC)	-2,265.62%	-1,171.61%	-710.61%	-604.03%	-620.72%	-513.07%	-313.30%	-290.10%	-308.72%	-277.69%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (ROA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	-61.50%	-47.95%	-79.48%	-58.59%	-44.08%	-37.18%	-39.75%	-34.43%	-30.24%	-28.82%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-41.60%	-74.01%	-52.92%	0.00%	-33.37%	-48.66%	-41.12%	0.00%	-33.61%
Net Operating Profit after Tax (NOPAT)	-22	-18	-16	-16	-12	-13	-8.55	-8.48	-7.61	-7.37
NOPAT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Nonoperating Expense Percent (NNEP)	-4.73%	-3.46%	-6.91%	-4.50%	-3.19%	-3.17%	-2.96%	-1.94%	-2.28%	-2.38%
Return On Investment Capital (ROIC_SIMPLE)	-11.02%	-	-	-	-7.40%	-	-	-	-	-
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings before Interest and Taxes (EBIT)	-31	-26	-23	-22	-18	-18	-12	-12	-11	-11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-32	-28	-24	-24	-19	-19	-13	-13	-11	-10
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.07	3.50	5.47	5.65	4.53	3.49	4.15	2.26	1.64	1.52
Price to Tangible Book Value (P/TBV)	3.07	3.50	5.47	5.65	4.53	3.49	4.15	2.26	1.64	1.52
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	205.15	78.16	68.95	109.16	113.64	80.67	32.63	13.90	9.65	8.13
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.16	0.13	0.26	0.22	0.19	0.18	0.30	0.27	0.24	0.22
Long-Term Debt to Equity	0.16	0.13	0.26	0.22	0.19	0.18	0.30	0.27	0.24	0.22
Financial Leverage	-0.98	-0.97	-0.92	-0.93	-0.95	-0.95	-0.91	-0.91	-0.93	-0.93
Leverage Ratio	1.25	1.22	1.37	1.31	1.28	1.25	1.29	1.26	1.25	1.23
Compound Leverage Factor	2.16	0.00	1.31	1.23	2.37	0.00	1.21	1.18	1.18	1.22
Debt to Total Capital	13.44%	11.75%	20.66%	17.82%	15.80%	15.21%	23.01%	21.02%	19.48%	18.25%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	13.44%	11.75%	20.66%	17.82%	15.80%	15.21%	23.01%	21.02%	19.48%	18.25%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	86.56%	88.25%	79.34%	82.18%	84.20%	84.79%	76.99%	78.98%	80.52%	81.75%
Debt to EBITDA	-0.25	-0.28	-0.31	-0.35	-0.41	-0.47	-0.55	-0.60	-0.68	-0.68
Net Debt to EBITDA	1.57	2.03	1.10	1.55	2.11	2.51	1.66	2.03	2.61	2.84
Long-Term Debt to EBITDA	-0.25	-0.28	-0.31	-0.35	-0.41	-0.47	-0.55	-0.60	-0.68	-0.68
Debt to NOPAT	-0.37	-0.42	-0.47	-0.54	-0.63	-0.71	-0.82	-0.87	-0.96	-0.96
Net Debt to NOPAT	2.35	3.07	1.67	2.37	3.24	3.81	2.47	2.95	3.67	4.00
Long-Term Debt to NOPAT	-0.37	-0.42	-0.47	-0.54	-0.63	-0.71	-0.82	-0.87	-0.96	-0.96
Altman Z-Score	4.99	8.62	4.89	8.24	7.88	6.46	3.28	1.25	0.72	1.12
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	13.73	17.70	11.31	14.90	15.66	18.98	18.33	23.90	21.98	26.55
Quick Ratio	13.33	17.16	10.77	14.58	15.32	18.77	17.87	23.32	21.45	25.97
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-19	-20	-14	-11	-8.76	-8.76	-6.76	-7.61	-6.61	-5.88
Operating Cash Flow to CapEx	0.00%	-755,600.00%	-107,119.05%	-206,440.00%	-65,012.50%	-30,604.65%	-4,565.33%	-300,650.00%	0.00%	-204,050.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1.74	6.46	6.70	5.23	4.40	4.57	8.75	9.62	7.98	8.45
Invested Capital Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	-2.66	1.89	-2.05	-4.39	-3.58	-3.87	-1.80	-0.86	-1.00	-1.49
Enterprise Value (EV)	357	505	462	571	500	369	285	134	77	69
Market Capitalization	527	698	557	688	636	511	364	222	177	177
Book Value per Share	$1.00	$1.21	$0.74	$0.88	$1.04	$1.08	$0.77	$0.86	$0.95	$1.02
Tangible Book Value per Share	$1.00	$1.21	$0.74	$0.88	$1.04	$1.08	$0.77	$0.86	$0.95	$1.02
Total Capital	198	226	128	148	167	173	114	124	134	143
Total Debt	27	27	26	26	26	26	26	26	26	26
Total Long-Term Debt	27	27	26	26	26	26	26	26	26	26
Net Debt	-170	-193	-95	-117	-136	-142	-79	-89	-100	-108
Capital Expenditures (CapEx)	-0.01	0.00	0.02	0.01	0.02	0.04	0.23	0.00	0.00	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-8.92	-5.83	-5.11	-6.67	-6.97	-7.12	-3.16	-2.07	-2.79	-2.17
Debt-free Net Working Capital (DFNWC)	187	214	116	136	155	161	102	113	123	132
Net Working Capital (NWC)	187	214	116	136	155	161	102	113	123	132
Net Nonoperating Expense (NNE)	7.22	5.80	6.01	4.61	3.76	3.97	2.89	2.08	2.69	3.01
Net Nonoperating Obligations (NNO)	-170	-193	-95	-117	-136	-142	-79	-89	-100	-108
Total Depreciation and Amortization (D&A)	-1.48	-1.34	-0.99	-1.24	-1.60	-1.38	-0.82	-0.83	-0.25	0.17
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.14)	($0.11)	($0.12)	($0.11)	($0.09)	($0.10)	($0.07)	($0.07)	($0.07)	($0.07)
Adjusted Weighted Average Basic Shares Outstanding	198.19M	211.85M	182.58M	182.55M	165.20M	164.34M	152.80M	152.78M	152.77M	152.77M
Adjusted Diluted Earnings per Share	($0.14)	($0.11)	($0.12)	($0.11)	($0.09)	($0.10)	($0.07)	($0.07)	($0.07)	($0.07)
Adjusted Weighted Average Diluted Shares Outstanding	198.19M	211.85M	182.58M	182.55M	165.20M	164.34M	152.80M	152.78M	152.77M	152.77M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	172.63M	171.62M	164.60M	138.19M	138.15M	135.34M	135.17M	114.07M	114.06M	114.04M
Normalized Net Operating Profit after Tax (NOPAT)	-22	-18	-16	-16	-12	-13	-8.55	-8.48	-7.61	-7.37
Normalized NOPAT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Pre Tax Income Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-1.04%	-1.35%	-1.61%	-1.87%	-2.21%	-0.38%	-0.01%	-0.01%	-0.01%	-0.20%

Frequently Asked Questions About Savara's Financials

When does Savara's financial year end?

According to the most recent income statement we have on file, Savara's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Savara's net income changed over the last 2 years?

Savara's net income appears to be on an upward trend, with a most recent value of -$95.88 million in 2024, rising from -$38.15 million in 2022. The previous period was -$54.70 million in 2023. See Savara's forecast for analyst expectations on what’s next for the company.

What is Savara's operating income?

Savara's total operating income in 2024 was -$103.20 million, based on the following breakdown:

Total Gross Profit: $0.00
Total Operating Expenses: $103.20 million

How has Savara revenue changed over the last 2 years?

Over the last 2 years, Savara's total revenue changed from $0.00 in 2022 to $0.00 in 2024, a change of 0.0%.

How much debt does Savara have?

Savara's total liabilities were at $41.43 million at the end of 2024, a 11.4% increase from 2023, and a 29.5% increase since 2022.

How much cash does Savara have?

In the past 2 years, Savara's cash and equivalents has ranged from $15.13 million in 2024 to $52.10 million in 2022, and is currently $15.13 million as of their latest financial filing in 2024.

How has Savara's book value per share changed over the last 2 years?

Over the last 2 years, Savara's book value per share changed from 0.95 in 2022 to 1.00 in 2024, a change of 5.7%.

Related Companies

This page (NASDAQ:SVRA) was last updated on 5/23/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Savara (SVRA) Financials

Frequently Asked Questions About Savara's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Savara (SVRA) Financials

Annual Income Statements for Savara

Quarterly Income Statements for Savara

Annual Cash Flow Statements for Savara

Quarterly Cash Flow Statements for Savara

Annual Balance Sheets for Savara

Quarterly Balance Sheets for Savara

Annual Metrics And Ratios for Savara

Quarterly Metrics And Ratios for Savara

Frequently Asked Questions About Savara's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools